Brief: Renovorx Inc - On Oct 31, Co Received Formal Notice, The Staff Of The Nasdaq Had Granted The Co’S Request For Continued Listing On Nasdaq
06/11/2023 22:20
Nov 6 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX INC - ON OCT 31, CO RECEIVED FORMAL NOTICE, THE
STAFF
OF THE NASDAQ HAD GRANTED THE CO’S REQUEST FOR CONTINUED LISTING
ON NASDAQ
Source text for Eikon: ID:
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer